2MC0 | pdb_00002mc0

Structural Basis of a Thiopeptide Antibiotic Multidrug Resistance System from Streptomyces lividans:Nosiheptide in Complex with TipAS

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Protein Modification Annotation

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	Antibiotic binding domain of TipA-like multidrug resistance regulators	8033720	3001469	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	TipAS	e2mc0A1	A: alpha arrays	X: Type III secretion system domain-like	H: Antibiotic binding domain of TipA-like multidrug resistance regulators (From Topology)	T: Antibiotic binding domain of TipA-like multidrug resistance regulators	F: TipAS	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF07739	TipAS antibiotic-recognition domain (TipAS)	TipAS antibiotic-recognition domain	This domain is found at the C-terminus of some MerR family transcription factors. The domain has an alpha-helical globin-like fold [1]. The family includes Mta a central regulator of multidrug resistance in Bacillus subtilis.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	HTH-type transcriptional activator TipA	DNA binding binding nucleic acid binding transcription regulator activity DNA-binding transcription factor activity	-	-
B	nosiheptide	-	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR009061	Putative DNA-binding domain superfamily	Homologous Superfamily
A	IPR047057	MerR transcriptional regulator	Family
A	IPR012925	TipAS antibiotic-recognition domain	Domain
A	IPR036244	TipA-like multidrug resistance regulator, antibiotic-recognition domain	Homologous Superfamily
A	IPR000551	MerR-type HTH domain	Domain

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
B	3GL	Parent Component: GLU RESID: AA0487 PSI-MOD : 4-hydroxy-L-glutamic acid MOD:01434
B	BB9	Parent Component: CYS RESID: AA0487 , AA0241 , AA0242 , AA0243 , AA0244 , AA0466 , AA0467 , AA0485 , AA0541 PSI-MOD : 4-hydroxy-L-glutamic acid MOD:01434 , glycine thiazole-4-carboxylic acid MOD:00246 , L-serine thiazole-4-carboxylic acid MOD:00247 , L-phenylalanine thiazole-4-carboxylic acid MOD:00248 , L-cysteine thiazole-4-carboxylic acid MOD:00249 , L-isoleucine thiazole-4-carboxylic acid MOD:01389 , L-valine thiazole-4-carboxylic acid MOD:01390 , L-threonine thiazoline-4-carboxylic acid MOD:01408 , L-glutamate thiazole-4-carboxylic acid MOD:01815
B	DBU	Parent Component: THR RESID: AA0487 , AA0241 , AA0242 , AA0243 , AA0244 , AA0466 , AA0467 , AA0485 , AA0541 , AA0182 PSI-MOD : 4-hydroxy-L-glutamic acid MOD:01434 , glycine thiazole-4-carboxylic acid MOD:00246 , L-serine thiazole-4-carboxylic acid MOD:00247 , L-phenylalanine thiazole-4-carboxylic acid MOD:00248 , L-cysteine thiazole-4-carboxylic acid MOD:00249 , L-isoleucine thiazole-4-carboxylic acid MOD:01389 , L-valine thiazole-4-carboxylic acid MOD:01390 , L-threonine thiazoline-4-carboxylic acid MOD:01408 , L-glutamate thiazole-4-carboxylic acid MOD:01815 , dehydrobutyrine (Thr) MOD:00190 , (Z)-dehydrobutyrine (Thr) MOD:01471
B	MH6	Parent Component: SER RESID: AA0487 , AA0241 , AA0242 , AA0243 , AA0244 , AA0466 , AA0467 , AA0485 , AA0541 , AA0182 , AA0540 PSI-MOD : 4-hydroxy-L-glutamic acid MOD:01434 , glycine thiazole-4-carboxylic acid MOD:00246 , L-serine thiazole-4-carboxylic acid MOD:00247 , L-phenylalanine thiazole-4-carboxylic acid MOD:00248 , L-cysteine thiazole-4-carboxylic acid MOD:00249 , L-isoleucine thiazole-4-carboxylic acid MOD:01389 , L-valine thiazole-4-carboxylic acid MOD:01390 , L-threonine thiazoline-4-carboxylic acid MOD:01408 , L-glutamate thiazole-4-carboxylic acid MOD:01815 , dehydrobutyrine (Thr) MOD:00190 , (Z)-dehydrobutyrine (Thr) MOD:01471 , L-cysteine 3-hydroxy-2,5-pyridinedicarboxylic acid MOD:01814
B	NH2	RESID: AA0487 , AA0241 , AA0242 , AA0243 , AA0244 , AA0466 , AA0467 , AA0485 , AA0541 , AA0182 , AA0540 , AA0081 , AA0083 , AA0084 , AA0086 , AA0087 , AA0088 , AA0090 , AA0091 , AA0092 , AA0093 , AA0095 , AA0096 , AA0097 , AA0098 , AA0099 , AA0100 PSI-MOD : 4-hydroxy-L-glutamic acid MOD:01434 , glycine thiazole-4-carboxylic acid MOD:00246 , L-serine thiazole-4-carboxylic acid MOD:00247 , L-phenylalanine thiazole-4-carboxylic acid MOD:00248 , L-cysteine thiazole-4-carboxylic acid MOD:00249 , L-isoleucine thiazole-4-carboxylic acid MOD:01389 , L-valine thiazole-4-carboxylic acid MOD:01390 , L-threonine thiazoline-4-carboxylic acid MOD:01408 , L-glutamate thiazole-4-carboxylic acid MOD:01815 , dehydrobutyrine (Thr) MOD:00190 , (Z)-dehydrobutyrine (Thr) MOD:01471 , L-cysteine 3-hydroxy-2,5-pyridinedicarboxylic acid MOD:01814 , L-alanine amide MOD:00090 , L-asparagine amide MOD:00092 , L-aspartic acid 1-amide MOD:00093 , L-glutamine amide MOD:00095 , L-glutamic acid 1-amide MOD:00096 , glycine amide MOD:00097 , L-isoleucine amide MOD:00099 , L-leucine amide MOD:00100 , L-lysine amide MOD:00101 , L-methionine amide MOD:00102 , L-proline amide MOD:00104 , L-serine amide MOD:00105 , L-threonine amide MOD:00106 , L-tryptophan amide MOD:00107 , L-tyrosine amide MOD:00108 , L-valine amide MOD:00109

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.